Skip to site menu Skip to page content

Daily Newsletter

10 August 2023

Daily Newsletter

10 August 2023

Ipswich Hospital opens haemodialysis unit for CKD patients

The unit can provide 72 sessions of haemodialysis each week.

August 10 2023

Ipswich Hospital in Queensland, Australia, has opened an acute haemodialysis unit to improve access to inpatient dialysis for kidney disease patients.

The six-bed, purpose-built unit is part of the Queensland Government’s A$22m ($14.36m) Ipswich Hospital Expansion Minor Works project.

The expanded capacity means the new unit can provide 72 sessions of haemodialysis each week.

Queensland Minister for Health, Mental Health and Ambulance Services and Minister for Women Shannon Fentiman said: “We know that some people are required to travel up to three times a week to receive haemodialysis treatment for chronic kidney disease (CKD).

“It is fantastic to announce that Ipswich Hospital now offers a complete kidney service, which includes access to care from highly experienced nursing and medical staff, who are providing the best quality of care.

“The unit is equipped with cardiac monitoring to provide a higher level of care if required, lowering the number of transfers to the intensive care unit.”

One in three adults in Queensland is estimated to be at increased risk of developing CKD.

An estimated 24,000 adults in Queensland’s West Moreton region have at least one biomedical sign of the disease such as reduced kidney function.

The West Moreton Kidney Health Service currently supports around 1,000 CKD patients.

Bundamba MP Lance McCallum said: “The new facility will provide more than 3,700 occasions of service for people with CKD.

"This is great news for dialysis patients who will now have access to better health services closer to home.”

Earlier this year, the Queensland government awarded a tender for the A$710m Ipswich Hospital Stage II expansion project.

The expansion project will include 200 new beds, an emergency department, an acute clinical service building and six operating theatres, as well as a satellite medical imaging service and central sterilisation service department.

Construction company BESIX Watpac was selected to build the expansion.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close